Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 5,8,11,14-eicosatetraenamide, N-(2-hydroxyethyl)-
2. 5,8,11,14-eicosatetraenoylethanolamide
3. Anandamide (20.4,n-6)
4. Arachidonoyl Ethanolamide
5. Arachidonoylethanolamide
6. Arachidonylethanolamide
7. N-(2-hydroxyethyl)arachidonamide
8. N-arachidonoyl-2-hydroxyethylamide
9. N-arachidonoylethanolamide
10. N-arachidonoylethanolamine
1. Arachidonylethanolamide
2. 94421-68-8
3. Arachidonoyl Ethanolamide
4. N-arachidonoylethanolamine
5. N-arachidonoyl Ethanolamine
6. Arachidonoylethanolamide
7. (5z,8z,11z,14z)-n-(2-hydroxyethyl)icosa-5,8,11,14-tetraenamide
8. Aea
9. Anandamide (20.4, N-6)
10. N-arachidonoyl-2-hydroxyethylamide
11. Arachidonoyl-ea
12. N-(2-hydroxyethyl)anachidonamide
13. 5,8,11,14-eicosatetraenoylethanolamide
14. Anandamide(20:4, N-6)
15. Anandamide (20:4, N-6)
16. Arachidonic Acid N-(hydroxyethyl)amide
17. N-(5z,8z,11z,14z-eicosatetraenoyl)-ethanolamine
18. Ur5g69tjkh
19. Aea-d8
20. 5,8,11,14-eicosatetraenamide, N-(2-hydroxyethyl)-, (5z,8z,11z,14z)-
21. Chembl15848
22. Chebi:2700
23. 5,8,11,14-eicosatetraenamide, N-(2-hydroxyethyl)-, (all-z)-
24. [3h]anandamide
25. 924894-98-4
26. N-(5z,8z,11z,14z-icosatetraenoyl)-ethanolamide
27. Arachidonoylethanolamide (aea)
28. Unii-ur5g69tjkh
29. N-(2-hydroxyethyl)-5z,8z,11z,14z-eicosatetraenamide
30. Annh
31. [14c]anandamide
32. Arachidonyl Ethanolamide
33. N-(2-hydroxyethyl)-5,8,11,14-eicosatetraenamide (all-z)-
34. Anandamide [mi]
35. Schembl43143
36. Bspbio_001533
37. N-arachidonoylaminoethan-2-ol
38. Bml2-b09
39. Gtpl2364
40. Bdbm22988
41. Dtxsid301017453
42. Hms1361m15
43. Hms1791m15
44. Hms1989m15
45. Hms3402m15
46. Hms3649b09
47. Zinc3809850
48. (5z,8z,11z,14z)-n-(2-hydroxyethyl)-5,8,11,14-eicosatetraenamide
49. Lmfa08040001
50. Nae(20:4)
51. Akos015951333
52. Ccg-208077
53. Idi1_034003
54. Smp2_000328
55. Ncgc00161195-03
56. Ncgc00161195-04
57. Ncgc00161195-05
58. Ncgc00161195-06
59. Ncgc00161195-07
60. Ba166586
61. Anandamide (in Tocrisolvetrade Mark 100)
62. Arachidonylethanolamide, >=97.0% (tlc), Oil
63. L000111
64. Q410228
65. Sr-01000946635
66. Sr-01000946635-1
67. Brd-k42352790-001-03-8
68. (all-z)-n-(2-hydroxyethyl)-5,8,11,14-eicosatetraenamide
69. N-(2-hydroxyethyl)-5,8,11,14-eicosatetraenamide (all-z)
70. (5z,8z,11z,14z)- N-(2-hydroxyethyl)- 5,8,11,14-eicosatetraenamide
71. C20:4 Anandamide (aea), 5z,8z,11z,14z-eicosatetraenoylethanolamide, Neat Oil
72. E7y
| Molecular Weight | 347.5 g/mol |
|---|---|
| Molecular Formula | C22H37NO2 |
| XLogP3 | 5.4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 16 |
| Exact Mass | 347.282429423 g/mol |
| Monoisotopic Mass | 347.282429423 g/mol |
| Topological Polar Surface Area | 49.3 Ų |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 408 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 4 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Calcium Channel Blockers
A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)
Cannabinoid Receptor Agonists
Compounds that interact with and stimulate the activity of CANNABINOID RECEPTORS. (See all compounds classified as Cannabinoid Receptor Agonists.)
ABOUT THIS PAGE
A Anandamide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Anandamide, including repackagers and relabelers. The FDA regulates Anandamide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Anandamide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Anandamide supplier is an individual or a company that provides Anandamide active pharmaceutical ingredient (API) or Anandamide finished formulations upon request. The Anandamide suppliers may include Anandamide API manufacturers, exporters, distributors and traders.
Anandamide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Anandamide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Anandamide GMP manufacturer or Anandamide GMP API supplier for your needs.
A Anandamide CoA (Certificate of Analysis) is a formal document that attests to Anandamide's compliance with Anandamide specifications and serves as a tool for batch-level quality control.
Anandamide CoA mostly includes findings from lab analyses of a specific batch. For each Anandamide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Anandamide may be tested according to a variety of international standards, such as European Pharmacopoeia (Anandamide EP), Anandamide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Anandamide USP).
LOOKING FOR A SUPPLIER?
